coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Blackburn West PCN, Blackburn with Darwen (LAD) · Health Inequalities Profile

    PCN U34816 · NHS Lancashire and South Cumbria Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    47,411

    Registered population

    60.1% aged 18–64

    17.3%

    Aged 65+

    ICB 20.0% · England 17.9%

    21.1%

    Ethnic minority (non-White)

    18.6% Asian · England 9.6%

    53.4%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~22,253

    Core20 residents (est.)

    Resident basis; registered basis ~27,621 · see page 3

    7,082

    Hypertension register

    +3.51% in 3 yrs · England +5.60%

    689

    SMI register

    27.6% of Blackburn with Darwen (LAD)'s

    909

    COPD register

    Reviews +0.48% in 3 yrs

    Forecast to 2030

    7,696

    Hypertension patients, 2030

    +614 on today

    87.7%

    QRISK ≥20% on statins, 2030

    +9.58pp over 3 yrs

    3.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    78.5%
    Early MMR uptake and pre-school booster lag.

    In Q1 2025/26, 24-month MMR1 is 78.5% (below the 95.0% target by 16.5 pp), and age-5 MMR drops 9.7 pp from 96.3% to 86.6%.

    56.4%
    Cervical screening in younger women trails England.

    Coverage in women aged 25-49 is 56.4% against 59.4% in the borough and 66.8% in England, falling 5.3% from 2023 to 2025 (England -1.0%).

    72.8%
    Register blood pressure control and reviews exceed England.

    Hypertension treated to target reaches 72.8% (England 70.3%), alongside 85.7% for annual COPD reviews (England 76.4%) and 89.4% for heart failure reviews (England 78.5%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    The PCN serves 47,411 patients with 22.6% aged 0-17 and marked ethnic variations

    Across 47,411 registered patients, 22.6% are aged 0-17, compared with 24.0% in Blackburn with Darwen, 19.6% in the ICB and 19.6% in England. Patients aged 65+ represent 17.3%, against 13.5% in Blackburn with Darwen, 20.0% in the ICB and 17.9% in England. Associated area Census estimates record 18.6% Asian or Asian British residents, against 35.7% in Blackburn with Darwen, 9.4% in the ICB and 9.6% in England. Practice catchments diverge sharply: Asian residency is 62.4% at Family Practice and 55.6% at Limefield Surgery, but 9.9% at Redlam Surgery. Area Census estimates do not reflect registered patient ethnicity.

    Age profile

    0–1722.6%
    18–6460.1%
    65+17.3%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White78.9%
    Asian18.6%
    Other1.3%
    Mixed0.8%
    Black0.4%

    Older people · falls rows are Blackburn with Darwen (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Blackburn with Darwen LA)1,7242,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.7%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.4%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Blackburn with Darwen LA)9511,0219552024/25
    Falls deaths, all ages, per 100,000 (Blackburn with Darwen LA)16.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 53.4% across the PCN and varies sharply by practice

    Across the PCN, 53.4% of registered patients live in Core20 areas, against 59.6% in Blackburn with Darwen, 30.6% in the ICB and 21.0% in England. Core20 concentration is highest at Family Practice (93.2%), Redlam Surgery (64.0%) and Limefield Surgery (62.5%), while volume peaks at Little Harwood Health Centre (7,191 estimated patients) and Witton Medical Centre (5,554). Summed practice estimates (27,621) exceed the resident deciles 1 and 2 estimate (22,253), which may reflect differing population bases. Outreach requires balancing practice concentration with absolute patient volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Family Practice93.2% · 4,740 patients
    Redlam64.0% · 2,783 patients
    Limefield62.5% · 2,954 patients
    Little Harwood59.3% · 7,191 patients
    Witton49.2% · 5,554 patients
    Oakenhurst44.7% · 4,399 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    689

    SMI register

    1.44% recorded prevalence

    316

    Learning disability register

    0.66% recorded prevalence

    26

    Care homes, 788 beds

    In the PCN catchment

    9.9%

    Provide unpaid care

    Blackburn with Darwen (LAD), Census 2021

    Severe mental illness prevalence is 1.4% (689 patients), above Blackburn with Darwen (1.3%), the ICB (1.2%) and England (1.0%). Learning disability prevalence is 0.7% (316 patients), compared with 0.6% across Blackburn with Darwen, the ICB and England. The PCN catchment contains 26 care homes with 788 beds.

    Severe mental illness: physical health checks

    SMI prevalence is 1.4% (England 1.0%). Physical health checks trail England: 76.2% of patients received blood pressure checks (England 83.4%) and 74.5% received BMI checks (England 82.1%). Uncompleted checks may leave physical cardiovascular risks unmonitored.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,082

    Hypertension register

    +3.51%

    Register growth, 3 yrs

    Blackburn with Darwen (LAD) +4.97% · England +5.60%

    +5.95pp

    BP control, under 80

    ≤140/90 · +5.88pp aged 80+

    +614

    More patients by 2030

    Forecast 7,696 (15.90%)

    Hypertension case-finding and control

    Blackburn West PCN records hypertension prevalence of 14.8% (7,082 patients), slightly below England (15.2%), Blackburn with Darwen (15.0%) and the ICB (17.2%). Three-year register growth was +3.5% (+0.5 pp) from 2023 to 2025, trailing England (+5.6%), the borough (+5.0%) and the ICB (+6.3%). Conversely, treatment to target reached 72.8%, outperforming England (70.3%), the borough (68.0%) and the ICB (70.3%), while BP control for under-80s reached 70.6% against 67.8% nationally. Slower register expansion alongside strong clinical management may indicate unrecorded hypertension rather than lower disease burden, meaning systematic case-finding should be prioritised across lower-prevalence practices.

    Lipids and statins

    Patients with QRISK ≥ 20% treated with lipid-lowering therapy reached 63.1%, slightly behind England (63.6%) and Blackburn with Darwen (66.0%), despite rising +17.9% (+9.6 pp) from 2023 to 2025 (England +6.2%). Reviewing eligible patients could support further uptake.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202686,230£2.60£1.64£1.86£224,198
    Cardiovascular (all), 2025121,647£3.40£3.38£3.33£413,600

    In 2026, lipid-modifying drugs cost £2.60 per item across 86,230 items (spending £224,198), above England (£1.86), the borough (£1.83) and the ICB (£1.64), costing £63,810 more than at England's unit cost. Higher unit costs than comparators may reflect formulary mix, presenting a focus for prescribing review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +0.84%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −3.51%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.8% (3,021 patients) and COPD prevalence is 1.9% (909 patients). Recorded annual reviews exceed national benchmarks: 69.2% for asthma (England 65.7%) and 85.7% for COPD (England 76.4%). However, over three years from 2023 to 2025, asthma registers fell 3.5% (England +0.5%) and COPD registers fell 2.1% (England +2.6%). Applying the review rate leaves an estimated 929 asthma patients unreviewed, indicating that strong review achievement on registers may mask contracting case ascertainment.

    Cancer register and children's immunisation

    Cancer prevalence is 3.4% (1,607 patients) against England's 3.8%. In Q1 2025/26, MMR1 uptake at 24 months is 78.5%, below the 95.0% target by 16.5 pp. At age 5, first-dose MMR reaches 96.3% but second-dose coverage drops by 9.7 pp to 86.6% (below the 95.0% target by 8.4 pp). Slower early uptake and pre-school dose drop-off leave young cohorts vulnerable to preventable outbreaks.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months87.1%

    England 91.0%

    6-in-1 complete primary course at 24 months86.0%

    England 92.2%

    MMR dose 1 at 24 months78.5%

    England 88.3%

    MMR dose 2 at age 586.6%

    England 82.8%

    4-in-1 pre-school booster at age 582.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, across NHS Lancashire and South Cumbria ICB, 52.4% of cancers with a known stage (4,642 of 8,863) were diagnosed at stage 1 or 2, against 55.3% in England and 22.6 pp below the 75.0% national ambition by 2028. Known-stage completeness was 74.6% (8,863 of 11,883 cancers). System-wide, reaching 75.0% would require about 2,010 additional early-stage cases annually. Meanwhile, PCN cervical screening coverage in women aged 25-49 is 56.4%, below England's 66.8%, falling 5.3% over three years (England -1.0%). Lower uptake may delay presentation, reinforcing the need for targeted primary care screening recall.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, East Lancashire Hospitals NHS Trust achieved 81.5% on the 28-day faster diagnosis standard (exceeding the 75.0% standard) and 98.1% on 31-day treatment (standard 96.0%), but met 73.2% on the 62-day referral-to-treatment standard (standard 85.0%). Comparators on 62-day waits were 69.7% at Bolton NHS Foundation Trust, 75.0% at Lancashire Teaching Hospitals NHS Foundation Trust, 73.6% in NHS Lancashire and South Cumbria Integrated Care Board and 71.2% in England. For diagnostics, 32.7% waited 6+ weeks for cystoscopy at East Lancashire Hospitals NHS Trust (England 24.4%), while MRI waits of 6+ weeks were 0.4% (England 21.4%).

    Pathways within standard (%)East LancashireLancashireBoltonLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)81.5082.9080.4878.3979.32
    31-day treatment (96%)98.1189.4396.5093.6292.50
    62-day referral to treatment (85%)73.1675.0469.6673.6271.16
    Diagnostic waits over 6 weeks (%)East LancashireLancashireBoltonEngland
    MRI0.432.412.0521.40
    CT0.1514.9719.409.92
    Echocardiography0.0013.853.4828.48
    Colonoscopy0.950.001.3330.83
    Gastroscopy1.160.002.0629.02
    All 15 DM01 tests3.2526.6515.7823.14
    Community services activityBlackburn With Darwen residentsLancashire and South Cumbria ICB
    Care contacts535193,720
    Referrals23029,855
    Patients with a contact30565,335

    Community services (residents of Blackburn With Darwen), Jun 2026 (provisional). In Jun 2026 (provisional), community service contacts for Blackburn with Darwen residents recorded 195 of 535 contacts among adults aged 65+, representing 36.4% of total activity. With provider-level and PCN-level breakdowns not captured, these figures describe borough resident activity rather than PCN caseload. Community and intermediate care links remain vital as older residents navigate diagnostic and cancer pathways.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Overall patient satisfaction varies by 32.5 pp across practices, spanning 58.0% to 90.6%

    In 2025/26, overall QOF achievement ranged from 78.4% at Family Practice to 98.3% at Redlam Surgery against England's 92.5%. Clinical achievement reached 97.8% at Little Harwood Health Centre. However, vaccination achievement trailed England (55.2%) across five practices, falling to 15.6% at Family Practice and Oakenhurst Medical Practice across a 69.5 pp range.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Witton10549.279.8%76.8%90.6%
    Oakenhurst10944.763.4%75.5%83.8%
    Redlam Surgery11364.083.5%64.6%82.8%
    Limefield Surgery9962.576.4%71.5%79.2%
    Little Harwood11159.340.1%72.6%71.7%
    Family Practice9693.239.8%80.9%58.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBlackburn with Darwen (LAD)AssetPCNBlackburn with Darwen (LAD)
    Care homes (catchment)26 (788 beds)n/aSchools (catchment)88n/a
    Children's centres613Places of worship7099
    Libraries46Primary schools (LA maintained)3145
    Primary academies46Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Childhood MMR catch-up and pre-school recall

    In Q1 2025/26, 24-month MMR1 is 78.5% (16.5 pp below the 95.0% target; England 88.3%), and age-5 MMR drops 9.7 pp from 96.3% to 86.6% across 134 children. For discussion: audit 24-month and age-5 cohorts for missed MMR doses and offer flexible catch-up clinics and phone reminders. Moderate effort to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Combined SMI physical health check outreach

    SMI prevalence is 1.4% (689 patients vs England 1.0%), while 12-month BP checks are 76.2% (England 83.4%, LAD 77.1%, ICB 79.8%) and BMI checks are 74.5% (England 82.1%). For discussion: combine BP and BMI checks in medication reviews, assign outreach leads, and raise data sharing with mental health partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Hypertension case-finding and coding audit

    Hypertension prevalence is 14.8% (7,082 patients) vs LAD 15.0% and England 15.2% (crude gap +19 to +139), with 2023 to 2025 growth +3.5% vs England +5.6%. For discussion: search records for uncoded raised BP readings and offer opportunistic checks, starting at Family Practice (7.3%) and Limefield Surgery (12.1%). Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored access review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening equity recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Access and triage workflow review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Childhood MMR catch-up and pre-school recall (p12)MMR dose 1 coverage at 24 months · MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Combined SMI physical health check outreach (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Hypertension case-finding and coding audit (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15